Prices delayed by at least 15 minutes | Print


Beximco Pharmaceuticals Limited (BXP)

GDR (EACH REPR 1 ORD BDT10)
Sell: 37p|Buy: 40p|Change: 0 (0%)

Open 

38.5p


Previous close 

38.5p


Trade high 

39p


Volume 

33,310


Year high 

45.00p


Year low 

33.30p


Dividend yield 

6.53%


Market capitalisation 

£171.75 mn


P/E ratio 

4.97


ISIN 

US0885792061


This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Dividends

PreviousLatest
Record date18/11/202213/11/2023
Ex-dividend date17/11/202210/11/2023
Payment date27/03/202308/02/2024
Amount$0.033221$0.031754

Performance 18/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Beximco Pharmaceuticals Limited 0.00
More...

Company profile

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Sector 

Healthcare


News

Recent trades

DateTimePriceQuantityValue (£)
18/03/202411:09:1537.2510,0003,725.00
18/03/202411:08:2037.7710,0003,777.00
18/03/202409:50:173912,8104,995.90
18/03/202408:48:5439500195.00
15/03/202403:37:024010,0004,000.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.